2 completed, 2 terminated, 1 recruiting, 1 unknown. 6 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Completed 2, Terminated 2, Recruiting 1, Unknown 1 |
Follow Hodgkin Lymphoma: new trials by email Literature Review of Hodgkin Lymphoma trials Research Report on Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies Darzalex Faspro (Daratumumab and hyaluronidase-fihj), JH-DSA Semi-Quant Screen and Response Score - Hematologic Malignancy, Bone Marrow Transplant Rejection | Early Phase 1 | Recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 | 2024-09-19 | 2026-10-05 |
| An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma Anti CD30 CAR-T Cell Injection - Hodgkin Lymphoma, NK/T Cell Lymphoma | Early Phase 1 | Unknown | Zhejiang University | 9 | 2022-02-10 | 2022-01-26 |
| Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma CD19 RNA redirected autologous T-cells (RNA CART19 cells) - Hodgkin Lymphoma | Early Phase 1 | Terminated | University of Pennsylvania | 2 | 2015-11-01 | 2020-05-21 |
| Intra-Osseous Co-Transplant of UCB and hMSC cyclophosphamide, fludarabine phosphate, total-body irradiation - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Early Phase 1 | Completed | Case Comprehensive Cancer Center | 6 | 2015-07-22 | 2020-12-04 |
| Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors Nelfinavir - Non-Hodgkin Lymphoma, Hodgkin Lymphoma | Early Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 | 2014-07-01 | 2016-06-10 |
| Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies Stem cell transplantation - Hodgkin Lymphoma, Lymphocytic Leukemia | Early Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2001-03-14 | 2019-12-16 |
Hodgkin Disease (6) · Lymphoma, Non-Hodgkin (4) · Lymphoma (3) · Myelodysplastic Syndromes (3) · Neoplasms (3) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Acute (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Primary Myelofibrosis (2) · Anemia, Aplastic (1) · Castleman Disease (1) · Hematologic Neoplasms (1) · Immunoblastic Lymphadenopathy (1) · Leukemia (1) · Leukemia, Biphenotypic, Acute (1)
Hemic and Lymphatic Diseases (6) · Immune System Diseases (6) · Immunoproliferative Disorders (6) · Lymphatic Diseases (6) · Lymphoproliferative Disorders (6) · Neoplasms by Histologic Type (6) · Bone Marrow Diseases (3) · Hematologic Diseases (3) · Lymphoma (3) · Neoplasms (3) · Chronic Disease (2) · Disease Attributes (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Leukemia, Myeloid (2)
Cord Blood Stem Cell Transplantation (1) · Cyclophosphamide (1) · Cyclosporine (1) · Mesenchymal Stem Cell Transplantation (1) · Mycophenolic Acid (1) · Nelfinavir (1) · Stem Cell Transplantation (1) · Transplantation (1) · Whole-Body Irradiation (1) · daratumumab (1) · fludarabine phosphate (1)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · Case Comprehensive Cancer Center (1) · National Cancer Institute (NCI) (1) · University of Pennsylvania (1) · Zhejiang University (1)
United States (5) · China (1)
Christian B Gocke, MD, PhD (1) · Huang He, PhD (1) · Leland Metheny, MD (1) · Richard Ambinder, MD (1) · Susan Rheingold, MD (1) · Terry J Fry, M.D. (1)
P30CA043703 (1)